2024 ESMO大会:黑钻石治疗学展示了现实世界的NSCLC患者结果和非古典突变。 2024 ESMO Congress: Black Diamond Therapeutics presents real-world NSCLC patient outcomes with non-classical mutations.

黑钻石治疗学在2024年ESMO大会上介绍了研究结果,展示了非古典突变新诊断的非小细胞肺癌患者的现实治疗做法和患者结果。 Black Diamond Therapeutics presented findings at the ESMO Congress 2024, showcasing real-world treatment practices and patient outcomes for newly diagnosed non-small cell lung cancer (NSCLC) patients with non-classical mutations. 介绍强调了了解治疗方法的重要性及其在这一特定病人群体中的有效性,为正在进行的癌症研究和护理做法提供了宝贵的见解。 The presentation highlights the importance of understanding treatment approaches and their effectiveness in this specific patient population, contributing valuable insights to ongoing cancer research and care practices.